Sabra Health Care REIT (SBRA) Scheduled to Post Quarterly Earnings on Wednesday

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) is set to issue its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.33 per share for the quarter. Parties that are interested in registering for the company's conference call can do so using this link.

Sabra Health Care REIT Price Performance

Shares of SBRA stock traded up $0.01 on Wednesday, reaching $13.93. The company's stock had a trading volume of 1,688,609 shares, compared to its average volume of 2,016,664. The company has a quick ratio of 3.41, a current ratio of 3.41 and a debt-to-equity ratio of 0.86. Sabra Health Care REIT has a 12-month low of $10.30 and a 12-month high of $14.91. The company has a market capitalization of $3.22 billion, a P/E ratio of 278.60, a PEG ratio of 5.09 and a beta of 1.16. The stock's 50 day simple moving average is $14.07 and its 200-day simple moving average is $14.03.

Sabra Health Care REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 29th. Investors of record on Tuesday, February 13th were given a $0.30 dividend. The ex-dividend date was Monday, February 12th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.61%. Sabra Health Care REIT's dividend payout ratio (DPR) is presently 2,400.00%.

Analysts Set New Price Targets

SBRA has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft initiated coverage on Sabra Health Care REIT in a research report on Tuesday, January 30th. They issued a "buy" rating and a $21.00 price objective on the stock. Wedbush reiterated an "outperform" rating and issued a $17.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Finally, Mizuho increased their price objective on Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a "buy" rating in a research report on Wednesday, January 3rd. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Sabra Health Care REIT presently has a consensus rating of "Moderate Buy" and a consensus price target of $15.77.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.